Correlation Between Hard To and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Hard To and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hard To and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hard to Treat and X4 Pharmaceuticals, you can compare the effects of market volatilities on Hard To and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hard To with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hard To and X4 Pharmaceuticals.
Diversification Opportunities for Hard To and X4 Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Hard and XFOR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Hard to Treat and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Hard To is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hard to Treat are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Hard To i.e., Hard To and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Hard To and X4 Pharmaceuticals
If you would invest 101.00 in X4 Pharmaceuticals on October 12, 2024 and sell it today you would lose (44.00) from holding X4 Pharmaceuticals or give up 43.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
Hard to Treat vs. X4 Pharmaceuticals
Performance |
Timeline |
Hard to Treat |
X4 Pharmaceuticals |
Hard To and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hard To and X4 Pharmaceuticals
The main advantage of trading using opposite Hard To and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hard To position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.Hard To vs. American Scientf | Hard To vs. Ingen Technologies | Hard To vs. Lifeline Biotechnologies | Hard To vs. Bioelectronics Corp |
X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |